机器学习预测慢阻肺全因死亡:MLMP-COPD模型
本研究在COPDGene和ECLIPSE两个队列中,利用30个临床、肺功能及定量CT影像特征构建随机生存森林机器学习模型(MLMP-COPD),预测慢阻肺全因死亡。模型在COPDGene(2632例)和ECLIPSE(1268例)中C指数均≥0.7,显著优于BODE等四个现有死亡率指数(P<.05)。最高风险组死亡率77%,高于BODE最高分组的64%(P=.012)。
要点
- MLMP-COPD模型在COPDGene和ECLIPSE中C指数均≥0.7,优于BODE等四个指数。
- 主要预测因子为6分钟步行距离、FEV1占预计值百分比和年龄。
- 影像学预测因子中肺动脉与主动脉直径比最重要,模型已在线提供。
核心结论
- MLMP-COPD模型在两个慢阻肺队列中预测全因死亡优于四个现有模型。
- 机器学习性能与传统统计方法相似。
研究设计与样本
- 回顾性分析COPDGene和ECLIPSE队列中中度至重度慢阻肺患者。
- COPDGene训练集2632例,ECLIPSE验证集1268例。
- 输入30个临床、肺功能及定量CT影像特征,采用随机生存森林。
主要发现
- COPDGene中位随访6.4年、ECLIPSE中位随访7.2年,MLMP-COPD模型C指数均≥0.7。
- 模型显著优于所有测试的死亡率指数(P<.05)。
- 最高预测风险组死亡率77%,BODE最高分组(7-10分)死亡率64%(P=.012)。
- 主要预测因子为6分钟步行距离、FEV1占预计值百分比和年龄,影像学首推肺动脉与主动脉直径比。
关键数值与推荐
- MLMP-COPD模型C指数≥0.7(COPDGene和ECLIPSE)。
- 与所有测试死亡率指数比较P<.05。
- 最高MLMP风险组死亡率77% vs BODE最高分组64%(P=.012)。
临床怎么用
- 可在线使用MLMP-COPD模型(https://cdnm.shinyapps.io/cgmortalityapp/)评估慢阻肺患者死亡风险。
- 模型纳入临床、肺功能及CT影像特征,有助于风险分层。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: COPD is a leading cause of mortality. RESEARCH QUESTION: We hypothesized that applying machine learning to clinical and quantitative CT imaging features would improve mortality prediction in COPD. STUDY DESIGN AND METHODS: We selected 30 clinical, spirometric, and imaging features as inputs for a random survival forest. We used top features in a Cox regression to create a machine learning mortality prediction (MLMP) in COPD model and also assessed the performance of other statistical and machine learning models. We trained the models in subjects with moderate to severe COPD from a subset of subjects in Genetic Epidemiology of COPD (COPDGene) and tested prediction performance in the remainder of individuals with moderate to severe COPD in COPDGene and Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE). We compared our model with the BMI, airflow obstruction, dyspnea, exercise capacity (BODE) index; BODE modifications; and the age, dyspnea, and airflow obstruction index. RESULTS: We included 2,632 participants from COPDGene and 1,268 participants from ECLIPSE. The top predictors of mortality were 6-min walk distance, FEV1 % predicted, and age. The top imaging predictor was pulmonary artery-to-aorta ratio. The MLMP-COPD model resulted in a C index ≥ 0.7 in both COPDGene and ECLIPSE (6.4- and 7.2-year median follow-ups, respectively), significantly better than all tested mortality indexes (P < .05). The MLMP-COPD model had fewer predictors but similar performance to that of other models. The group with the highest BODE scores (7-10) had 64% mortality, whereas the highest mortality group defined by the MLMP-COPD model had 77% mortality (P = .012). INTERPRETATION: An MLMP-COPD model outperformed four existing models for predicting all-cause mortality across two COPD cohorts. Performance of machine learning was similar to that of traditional statistical methods. The model is available online at: https://cdnm.shinyapps.io/cgmortalityapp/.
引用
- Moll M, Qiao D, Regan EA, et al. Machine Learning and Prediction of All-Cause Mortality in COPD. Chest. 2020. PMID: 32353417. doi:10.1016/j.chest.2020.02.079
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。